| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |